Takeda Pharmaceutical Co Ltd
- SEC CIK
- 0001395064
No open-market purchases or sales filed in the past year.
Current role at each company
- OVID Ovid Therapeutics Inc.10% Owneras of Dec 9, 2025
- HLVX HilleVax, Inc.10% Owneras of Sep 19, 2025
- PHAT Phathom Pharmaceuticals, Inc.10% Owneras of Jan 25, 2024
- CALA Calithera Biosciences, Inc.Other: Former 10% Owneras of May 26, 2023
- DAWN Day One Biopharmaceuticals, Inc.10% Owneras of Dec 9, 2021
Show 2 more companies
- XLO Xilio Therapeutics, Inc.10% Owneras of Oct 26, 2021
- THRX Theseus Pharmaceuticals, Inc.10% Owneras of Oct 15, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Takeda Pharmaceutical Co Ltd as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PHAT Phathom Pharmaceuticals, Inc.
10% Owner5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 25, 2024 (view filing) | Jan 24 | 1 day | Takeda Pharmaceutical Co Ltd10% Owner | SSale | −3.70M | $8.10 | −$30.0M | −49.7%3.76M after | |
| Mar 16, 2022 (view filing) | Mar 14 | 2 days | Takeda Pharmaceutical Co Ltd10% Owner | SSale | −18 | $19.00 | −$342 | 0.0%7.46M after | |
| Nov 8, 2021 (view filing) | Nov 4 | 4 days | Takeda Pharmaceutical Co Ltd10% Owner | SSale | −1.00M | $20.85 | −$20.9M | −90.9%100.0K after | 2 lots |
| Jul 9, 2021 (view filing) | Jul 7 | 2 days | Takeda Pharmaceutical Co Ltd10% Owner | SSale | −2.61K | $35.05 | −$91.4K | −0.3%871.3K after | |
| Jul 6, 2021 (view filing) | Jul 1-2 | 5 days | Takeda Pharmaceutical Co Ltd10% Owner | SSale | −8.33K | $35.16 | −$292.7K | −0.9%873.9K after | 2 lots |
DAWN Day One Biopharmaceuticals, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2021 (view filing)6:04 AM ET | Dec 7-8 | 2 days | Millennium Pharmaceuticals Inc and 3 others10% Owner | SSale | −297.3K | $18.49 | −$5.50M | −4.6%6.12M after | 3 lots |
| Dec 7, 2021 (view filing)6:01 AM ET | Dec 3-6 | 4 days | Millennium Pharmaceuticals Inc and 3 others10% Owner | SSale | −110.2K | $18.10 | −$1.99M | −1.7%6.42M after | 2 lots |